| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.0M | -79.5% |
| Cost of Revenue | $23.9M | +7.1% |
| Gross Profit | $169K | -99.8% |
| R&D Expense | $4.5M | -20.0% |
| SG&A Expense | $43.9M | +1.9% |
| Operating Income | -$65.4M | -324.9% |
| Pre-tax Income | -$64.6M | -323.9% |
| Income Tax | $70.4M | +937.2% |
| Net Income | -$135.0M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $243.2M | +1.2% |
| Accounts Receivable | $5.1M | +9.5% |
| Current Assets | $275.7M | -4.9% |
| Total Assets | $296.4M | -20.8% |
| Current Liabilities | $47.3M | +129.5% |
| Long-term Debt | $139.7M | -3.0% |
| Total Liabilities | $218.3M | +29.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $17.6M | -78.7% |
| Capital Expenditures | $165K | +34.1% |
| Investing Cash Flow | -$3.9M | -78.9% |
| Financing Cash Flow | -$6.4M | +84.8% |
| Free Cash Flow | $17.4M | -78.9% |
| -711.7% |
| EPS (Basic) | -$1.13 | -727.8% |
| EPS (Diluted) | -$1.13 | -727.8% |
| Stockholders' Equity |
| $78.1M |
| -62.0% |